MedTech Dive July 24, 2024
Nick Paul Taylor

The first six months of the year brought a series of multibillion-dollar deals, led by Johnson & Johnson’s $13.1 billion takeover of Shockwave Medical.

The first half of 2024 brought a series of billion-dollar medtech deals across multiple sub-sectors.

Johnson & Johnson’s $13.1 billion takeover of Shockwave Medical easily tops the list as the most expensive purchase so far this year, but several other companies announced or closed large deals of their own, including BD and Boston Scientific.

Here, MedTech Dive looks at the industry’s top five acquisitions of the year and what they mean for the companies involved.

1. Johnson & Johnson buys Shockwave Medical

Amount: $13.1 billion

Date closed: May 31

J&J agreed to buy Shockwave for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article